An interventional study of OCT Imaging in Pediatric Idiopathic Intracranial Hypertension, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2016-01-28.
Sponsored by Hillel Yaffe Medical Center · Not applicable, Interventional, and Diagnostic
Longitudinal clinical observation of optic nerve head, using slit lamp fundoscopy, guides therapy in pediatric idiopathic intracranial hypertension (IIH) patients; however, it remains a limited method of producing quantitative data in evaluating in patients with IIH.
In this study we intend to compare, by using spectral domain optical coherence tomography (OCT), the mean retinal nerve fiber layer thickness and total retinal thickness (RNFLT/TRT) of the optic nerve of newly diagnosed IIH children to a control group. This will provide a quantitative measure for follow-up and treatment of this patient group.
185 studies on the registry are indexed under Intracranial Hypertension; 45 are open to participants now.
This study's planned enrollment of 50 is close to the median of 50 across 95 interventional studies indexed under Intracranial Hypertension.
Browse Intracranial Hypertension studies →Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients diagnosed with Idiopathic Intracranial Hypertension who undergo OCT imaging
Other: OCT Imaging
Patients diagnosed with headache with ruled out Idiopathic Intracranial Hypertension who undergo OCT imaging
Other: OCT Imaging
Comparison of RNFLT/TRT Thickness
Time frame: One year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hillel Yaffe Medical Center